Boston Scientific Shares Slip as Major Indexes Advance
The stock closed lower as the S&P 500, Dow and Nasdaq rose, with Boston Scientific’s next earnings report due October 28.
Boston Scientific shares closed at $42.60 on Friday, down 1.46% from the previous session. The S&P 500 rose 0.73%, the Dow gained 0.49% and the Nasdaq advanced 1.19%.
In the month leading up to the session, Boston Scientific shares had fallen 7.92%. The Medical sector was down 3.74% over the same period, while the S&P 500 rose 0.55%.
The company is scheduled to report quarterly results on October 28. Analysts expect earnings of $0.76 per share and revenue of $5.23 billion, up 1.33% and 3.25%, respectively, from a year earlier.
For the full year, Zacks consensus estimates call for earnings of $3.25 per share and revenue of $21.22 billion. Those figures would represent year-over-year increases of 6.21% and 5.72%. The consensus earnings estimate has fallen 1.3% over the past 30 days.
Boston Scientific’s forward P/E ratio was 13.28, compared with an industry average of 19.67. Its PEG ratio was 1.04, versus 1.71 for the Medical - Products industry.
This article was produced with the help of AI technology. Source: Yahoo Finance